Atrial Fibrillation and Stroke Risk | Healos™
Atrial Fibrillation and Stroke: Why an Irregular Heartbeat Can Lead to a Stroke
Many people only learn they have atrial fibrillation after a stroke, or after a smartwatch alert they weren't sure whether to take seriously. AF is the most common heart rhythm problem, and it's one of the most important, and most preventable, causes of stroke.
Here is the short answer. In atrial fibrillation, the upper chambers quiver instead of beating, so blood pools and can form clots that travel to the brain. AF raises stroke risk about fivefold, and AF-related strokes tend to be more severe. Anticoagulants cut that risk by about two-thirds. Because AF often comes and goes without symptoms, longer heart monitoring after a stroke can find it in people who'd otherwise be missed.
简短的答案： 很多人是在中风之后，或在一次不知该不该当真的智能手表提醒之后，才知道自己有房颤。房颤是最常见的心律问题，也是卒中最重要、最可预防的原因之一。
房颤时心房颤动而不是有力跳动，血液淤积可能形成血栓并流到大脑；房颤使卒中风险增加约五倍，房颤相关的卒中往往更严重；抗凝药能把风险降低约三分之二；由于房颤常时有时无、没有症状，卒中后延长心律监测能发现原本会被漏掉的房颤。
How atrial fibrillation causes a stroke
Normally, the heart's upper chambers (the atria) contract in a steady rhythm and push blood into the lower chambers. In AF, their electrical activity becomes chaotic, and they quiver rather than squeeze. Blood moves sluggishly, especially in a small pouch called the left atrial appendage, where clots can form. If a clot breaks free, it can travel straight to the brain and block an artery.
In the Framingham Study, AF was associated with about a fivefold increase in stroke risk (Wolf et al., Stroke, 1991). Strokes caused by AF clots tend to be larger and more disabling, because the clots are often big enough to block major brain arteries (see clot-busting drugs vs clot retrieval).
房颤如何导致卒中： 正常情况下，心脏的上腔（心房）有节律地收缩，把血液推入下腔。房颤时电活动变得混乱，心房只是颤动而不是挤压，血流变慢，尤其在一个叫左心耳的小囊里，血栓可能在那里形成；血栓一旦脱落，就可能直接流到大脑堵塞动脉。
Framingham 研究中，房颤使卒中风险增加约五倍（Stroke 1991）。房颤血栓引起的卒中往往更大、更致残，因为血栓常大到足以堵住大脑的主要动脉。
Blood thinners: the main protection
For most people with AF and other stroke risk factors, an anticoagulant is the key protection, and it works far better than aspirin. Warfarin reduced stroke by about 64% in people with AF, compared with about 22% for antiplatelet therapy (Hart et al., Annals of Internal Medicine, 2007).
Most people now take a direct oral anticoagulant (DOAC), such as apixaban, rivaroxaban, edoxaban or dabigatran. Compared with warfarin, DOACs reduced stroke or systemic embolism by about 19% and roughly halved bleeding inside the skull (Ruff et al., Lancet, 2014), without routine blood tests. Warfarin is still used with mechanical heart valves and some other conditions.
Who needs one? In Canada, cardiologists commonly use the CHADS-65 approach from Canadian Cardiovascular Society guidelines: most people aged 65 or older with AF, or younger people with risk factors such as high blood pressure, diabetes, heart failure or a previous stroke, are advised to take an anticoagulant. Your doctor weighs this against bleeding risk (see stroke medications explained).
抗凝药：主要的保护： 对大多数有房颤和其他卒中危险因素的人来说，抗凝药是关键的保护，效果远好于阿司匹林：房颤患者中，华法林使卒中减少约 64%，抗血小板药约 22%（Ann Intern Med 2007）。
如今多数人服用新型口服抗凝药（DOAC），如阿哌沙班、利伐沙班、艾多沙班或达比加群；与华法林相比，DOAC 使卒中或全身栓塞减少约 19%，颅内出血大约减半（Lancet 2014），且不需要常规验血；机械瓣等情况仍用华法林。
谁需要？在加拿大，心脏科医生常用加拿大心血管学会指南中的 CHADS-65 方法：多数 65 岁及以上的房颤患者，或有高血压、糖尿病、心衰、既往卒中等危险因素的年轻患者，都建议服用抗凝药；医生会权衡出血风险。
Why AF is so often missed, and how it's found
AF can come and go (paroxysmal AF) and often causes no symptoms at all. A standard ECG or a 24-hour monitor can easily miss it. That matters after a stroke whose cause isn't clear: finding AF changes treatment from aspirin to an anticoagulant.
In the Canadian EMBRACE trial, 30-day heart monitoring after an unexplained stroke or TIA found AF in 16.1% of patients, compared with 3.2% with standard 24-hour monitoring (Gladstone et al., NEJM, 2014). If your stroke's cause wasn't found, ask whether longer monitoring is appropriate.
Smartwatches can flag possible AF. An alert isn't a diagnosis, but it's worth showing your doctor, who can confirm it with an ECG.
房颤为什么常被漏掉，以及如何发现： 房颤可能时有时无（阵发性房颤），也常常完全没有症状，普通心电图或 24 小时监测很容易漏掉。这在病因不明的卒中后很重要：发现房颤，会让治疗从阿司匹林改为抗凝药。
加拿大 EMBRACE 试验中，对原因不明的卒中或 TIA 患者做 30 天心律监测，16.1% 发现房颤，而标准 24 小时监测只有 3.2%（NEJM 2014）。如果你的卒中原因没有找到，可以询问是否需要更长时间的监测。
智能手表可以提示可能的房颤，提醒不等于诊断，但值得给医生看，医生可以用心电图确认。
Living safely on an anticoagulant
Never stop or skip it without your doctor; protection fades within a day or two for DOACs.
Know the bleeding red flags: black or bloody stools, vomiting blood, a severe headache, a fall with a head injury. Seek care urgently.
Tell every clinician and dentist you take it.
Check supplements: high-dose fish oil, vitamin E, ginkgo, garlic and turmeric can add bleeding risk, and some products interact with warfarin (see the medication-nutrient map).
Timing after a stroke is decided by your stroke team; recent research supports starting earlier than once thought for many people.
Remember BE FAST and call 911 for any new stroke signs.
安全地服用抗凝药：
没有医生同意，绝不停药或漏服——DOAC 的保护作用一两天内就会消退；
了解出血红旗：黑便或血便、呕血、剧烈头痛、跌倒伤及头部，请紧急就医；
告诉每一位医生和牙医你在服用；
核查补充剂：高剂量鱼油、维生素 E、银杏、大蒜和姜黄可能增加出血风险，部分产品还会与华法林相互作用；
卒中后何时开始抗凝由卒中团队决定，近期研究支持很多人可以比过去认为的更早开始。
任何新的卒中征兆，记住 BE FAST，拨打 911。
How Healos™ supports recovery
Healos™ never replaces or adjusts anticoagulants. Every kit is pharmacist-reviewed against your medication list before it ships, with a specific check for blood thinners: tell us at checkout and your kit is adjusted. The 91-Day Protocol moves through Detox, Replenish and Repair, with stroke-specific complementary nutrition, follow-ups at day 30 and day 60 (with a reminder to book your blood test) and a blood-test report review at day 90. Sovereign Monthly · Recovery continues month to month.
Healos™ 如何支持康复： Healos™ 绝不替代或调整抗凝药。每份营养包发货前都由药剂师按你的用药清单审核，并专门核查抗凝药：结账时告诉我们，营养包会相应调整。91 天方案依次经过排毒、补给、修复，提供卒中专属的辅助营养，第 30 天跟进、第 60 天跟进并提醒验血、第 90 天验血报告解读；Sovereign Monthly · Recovery 按月延续。
The bottom line
Atrial fibrillation lets clots form in the heart, raises stroke risk about fivefold and tends to cause more severe strokes. Anticoagulants cut that risk dramatically, and longer monitoring can find AF that standard tests miss. If you have AF, ask whether you need a blood thinner; if you've had an unexplained stroke, ask about longer monitoring; and if you take an anticoagulant, take it every day and check every supplement first.
结论： 房颤让血栓在心脏内形成，使卒中风险增加约五倍，引起的卒中往往更严重。抗凝药能大幅降低这种风险，延长监测能发现常规检查漏掉的房颤。如果你有房颤，问问是否需要抗凝药；如果卒中原因不明，问问是否需要更长时间的监测；如果正在服用抗凝药，每天按时吃，任何补充剂先核查。
Frequently asked questions
Why does atrial fibrillation cause a stroke? In AF the upper heart chambers quiver instead of beating, so blood pools, especially in the left atrial appendage, and clots can form and travel to the brain. AF raises stroke risk about fivefold.
Do I need a blood thinner for atrial fibrillation? Many people do. Canadian guidance commonly recommends an anticoagulant for people with AF aged 65 or older, or younger with risk factors such as high blood pressure, diabetes, heart failure or a previous stroke, weighed against bleeding risk.
Can a smartwatch detect atrial fibrillation? Smartwatches can flag possible AF, but an alert isn't a diagnosis. Show it to your doctor, who can confirm AF with an ECG.
How long should I be monitored for AF after a stroke? If the cause of your stroke wasn't found, longer monitoring helps: in the Canadian EMBRACE trial, 30-day monitoring found AF in 16.1% of patients versus 3.2% with 24-hour monitoring.
常见问题：
房颤为什么会导致中风？心房颤动、血液淤积（尤其在左心耳）形成血栓并流到大脑，风险约增加五倍。
房颤一定要吃抗凝药吗？很多人需要，加拿大常用 CHADS-65：65 岁以上，或较年轻但有高血压、糖尿病、心衰、既往卒中等，一般建议抗凝，并权衡出血风险。
智能手表能发现房颤吗？能提示，但不等于诊断，请给医生看并用心电图确认。
中风后要监测多久？病因不明时延长监测更好，EMBRACE 中 30 天监测发现 16.1%，24 小时只有 3.2%。
References
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–988.
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine. 2007;146(12):857–867.
Ruff CT, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation. Lancet. 2014;383(9921):955–962.
Gladstone DJ, et al. Atrial fibrillation in patients with cryptogenic stroke (EMBRACE). New England Journal of Medicine. 2014;370:2467–2477.
Andrade JG, et al. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation. Canadian Journal of Cardiology. 2020;36(12):1847–1948.
